Ashland (NYSE:ASH) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Ashland (NYSE:ASH) released its quarterly earnings results on Wednesday. The basic materials company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.28 by ($0.02), Briefing.com reports. Ashland had a return on equity of 5.98% and a net margin of 7.01%. The business had revenue of $522.00 million during the quarter, compared to analyst estimates of $524.07 million. During the same period in the previous year, the company posted $0.41 EPS. The business’s revenue for the quarter was up .8% compared to the same quarter last year. Ashland updated its FY 2025 guidance to EPS.

Ashland Price Performance

NYSE:ASH opened at $81.01 on Friday. Ashland has a one year low of $71.55 and a one year high of $102.50. The stock has a market cap of $3.96 billion, a PE ratio of 27.46, a P/E/G ratio of 1.14 and a beta of 0.88. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.84 and a current ratio of 2.98. The stock has a 50 day moving average price of $85.96 and a 200 day moving average price of $91.56.

Analysts Set New Price Targets

Several research analysts have recently weighed in on ASH shares. JPMorgan Chase & Co. raised Ashland from an “underweight” rating to a “neutral” rating and reduced their target price for the stock from $90.00 to $89.00 in a research note on Thursday, August 8th. BMO Capital Markets dropped their target price on shares of Ashland from $105.00 to $92.00 and set a “market perform” rating on the stock in a research report on Friday, August 9th. UBS Group decreased their price target on shares of Ashland from $116.00 to $107.00 and set a “buy” rating on the stock in a research note on Thursday, August 15th. Wells Fargo & Company cut their price objective on Ashland from $112.00 to $100.00 and set an “overweight” rating for the company in a research note on Thursday, August 8th. Finally, StockNews.com cut Ashland from a “buy” rating to a “hold” rating in a report on Friday, September 13th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $103.50.

About Ashland

Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.